New study to track recovery in elderly neurosurgery patients across europe
NCT ID NCT07506941
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 209 adults aged 65 and older who are hospitalized for neurosurgery in France, Spain, or Portugal. Researchers will measure changes in their ability to perform daily activities (like bathing, dressing, eating) from before surgery to 3 months after. The goal is to understand how well these patients recover and what care pathways they follow, so hospitals can better meet their needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 209 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged 65 years or older admitted for neurosurgical intervention, for whom follow-up for 3 months is possible given their cognitive status and life expectancy, and who agrees to the retrieval of their hospital clinical and health economic data during the year following their discharge from the hospital
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: Age ≥ 65 years at the time of admission Admission to a neurosurgery department in one of the participating centres (France, Spain, or Portugal), Affiliation with a national health-insurance or equivalent system Feasibility of follow-up at 3 months, Consent/non-opposition for the study Exclusion Criteria: Terminal illness (neurosurgical or not) with an estimated life expectancy of \< 3 months. Loss of autonomy prior to admission, established as ADL \< 3. For a patient admitted to the emergency hospital, ask him (or his caregiver) about his functional abilities before his condition deteriorated. Legal protection status (guardianship, trusteeship, or judicial protection) when such status prevents lawful consent or non-opposition. Participation in another interventional clinical study whose procedures or follow-up could interfere with GENEUS 1 objectives or endpoints. Severe cognitive or communication impairment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ageing and geriatric health are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
6 sites in 3 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CUF Descobertas
Lisbon, Portugal
-
Complexo Hospitalario De Ourense
Ourense, Spain
-
Hospital General Universitario Alicante
Alicante, Spain
-
Limoges University Hospital
Limoges, France
-
Navarrabiomed
Pamplona, Spain
-
ULS Santa Maria
Lisbon, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.